Brian R. Edlin, MD

Articles by Brian R. Edlin, MD

Value of Expanding HCV Screening and Treatment Policies in the United States

ByMark T. Linthicum, MPP,Yuri Sanchez Gonzalez, PhD,Karen Mulligan, PhD,Gigi A. Moreno, PhD,David Dreyfus, DBA,Timothy Juday, PhD,Steven E. Marx, PharmD,Darius N. Lakdawalla, PhD,Brian R. Edlin, MD,Ron Brookmeyer, PhD

May 3rd 2016

Expanding screening for hepatitis C virus infection may generate substantial benefits for patients and society, but only when paired with expanded treatment policies.

Latest Updated Articles

Value of Expanding HCV Screening and Treatment Policies in the United States
Published: May 3rd 2016 | Updated:

Brian R. Edlin, MD

Articles by Brian R. Edlin, MD

Value of Expanding HCV Screening and Treatment Policies in the United States

Latest Updated Articles

Trending on AJMC

FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis

Weight Loss Medications Show Promise in MASLD, MASH

HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs

How Medicaid Reforms Could Deepen State Coverage Gaps

Addressing Common Stigmas in Weight Loss: David Rometo, MD